Curated News: Medical Meetings

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

To compare the outcomes of patients receiving lungs transplanted after undergoing ex vivo lung perfusion (EVLP) versus those transplanted conventionally at the Toronto General Hospital, Aadil Ali, PhD, and coauthors looked at 14 years of data from the Toronto Lung Transplant Database.

• share
• favorite_border

In 2011, Makoto Suzuki, MD, and a team of associates from across Japan embarked on a long-term study of the safety and efficacy of sublobar resections for ground-glass opacity–dominant (GGO) peripheral lung cancer.

• share
• favorite_border

Among the questions that cancer patients ask following their surgeries are, “Will it come back? Do I need additional treatment?”

• share
• favorite_border

Congenital heart disease (CHD) is the most common type of birth defect and the leading cause of mortality from birth defects, affecting about 1% of all live births per year in the United States. With advances in medical therapies and surgical techniques, the survival outcomes of patients with CHD have improved dramatically over the years.

• share
• favorite_border

Although the On-X aortic valve and apixaban have been approved for use by the U.S. Food and Drug Administration (FDA), they had not been approved to be used together. Between May 2020 and September 2022, the PROACT Xa randomized, multicenter, open-label trial compared the direct factor Xa inhibitor apixaban (Eliquis) with warfarin in patients with bileaflet carbon aortic valves.

• share
• favorite_border

Lung transplantation is routinely performed at night because of the unpredictability of donor organ procurement. Late start-times for complex operations such as lung transplantation have been associated with adverse outcomes.

• share
• favorite_border

As thoracic researchers consider the myriad effects of COVID-19, they are looking at the impacts of the disease on patients and treatments, as well as care and treatment during the pandemic.

• share
• favorite_border

The American Association for Thoracic Surgery (AATS) is committed to diversity, equity, and inclusion. A wealth of data has shown that diversity in the physician workforce improves patient care, safety, physician well-being, and innovation; and fair compensation is essential to culturing a diverse workforce.

• share
• favorite_border

The effects of the COVID-19 pandemic have rumbled through every piece of society, and nowhere more dramatically than in the medical communities.

• share
• favorite_border

Lung cancer is the most common cause of cancer-related deaths in North America. Although cigarette smoking remains the main risk factor for lung cancer development, the importance of environmental factors such as pollution and poor air quality is becoming increasingly recognized.

• share
• favorite_border

Hypoplastic left heart syndrome (HLHS) is a birth defect that affects normal blood flow through the heart. As the baby develops during pregnancy, the left side of the heart does not form correctly. The Centers for Disease Control and Prevention (CDC) estimates that each year about 1,025 babies in the United States are born with hypoplastic left heart syndrome—about one out of every 3,841 babies each year.

• share
• favorite_border

Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has selected visually impaired professional triathlete Amy Dixon as keynote speaker for its 2023 Patient Summit, to be held in Long Beach, California, June 23-24.

• share
• favorite_border

Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. DDW2023 will take place May 6-9 in Chicago and showcase 3,100 abstracts and hundreds of lectures on the latest advances in GI research, clinical practice and technology.

• share
• favorite_border

The American Society of Retina Specialists (ASRS) invites members of the press to cover the latest advances in retina science and practice during its 41st Annual Scientific Meeting July 28 – August 1.

• share
• favorite_border

Throughout the American Association for Thoracic Surgery (AATS) Annual Meeting, taking place May 6-9 in Los Angeles, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiothoracic surgery.

• share
• favorite_border

The program guide for TVT 2023: The Structural Heart Summit is available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions and will take place June 7-10, 2023, at the Phoenix Convention Center – West in Phoenix, Arizona.

• share
• favorite_border

This week, 18 Smilow Cancer Hospital nurses will present new oncologic research at the 48th Annual Congress of the Oncology Nursing Society in San Antonio, Texas. Their findings will be revealed during poster and oral presentation sessions from April 26th through April 30th. Some of the featured oral presentation topics include “Designing a Novel Educational Program to Decrease Ambulatory Falls with Injury,” “Monoclonal Antibody Education for Non-Oncology RNs,” and “Oncology Advanced Practice Provider Productivity: Measuring and Justifying our Worth.

• share
• favorite_border

Novel research in sexual health by investigators at the Desai Sethi Urology Institute (DSUI) at the University of Miami Miller School of Medicine was presented at the 2023 American Urological Association (AUA), one of the world's most important urology meetings, and simultaneously published in, the Journal of Urology, one of the highest impact journals in the specialty.